Zimmer Biomet Holdings ZBH
$101.10 −$0.37 (-0.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $100.82 -0.28%
Open$102.72
Prev close$101.47
Day range$100.82 – $103.87
Volume2.96M
Market cap$19.13B
P/E (TTM)25.5
Dividend yield0.95%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$2.06B+3.1% YoY
Operating profit$341.50M+0.9% YoY
Net profit$192.90M-16.6% YoY
Diluted EPS$1.00-13.8% YoY
Free cash flow$459.20M+29.8% YoY
Operating cash flow$560.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin69.7%
Operating margin16.3%
Net margin9.0%
Return on equity6.0%
Return on assets3.3%
Return on invested capital5.0%
Current ratio1.46
Liabilities / assets45.9%
Cash & investments$399.90M
Total debt$7.50B
Net cash (debt)-$7.10B
Free cash flow / sales17.6%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $2.06B | $2.18B | $2.09B | $8.23B | $2.24B |
| Total Operating Revenue | $2.06B | $2.18B | $2.09B | $8.23B | $2.24B |
| Cost of Revenue | $594.50M | $635.50M | $576.20M | $2.49B | $792.40M |
| Gross Profit | $1.47B | $1.54B | $1.51B | $5.74B | $1.45B |
| Operating Expense | $1.13B | $1.17B | $1.12B | $4.38B | $1.17B |
| Selling and Admin Expenses | $855.00M | $899.30M | $849.90M | $3.26B | $872.30M |
| Research & Development | $105.90M | $104.80M | $103.40M | $458.50M | $118.70M |
| Depreciation & Amortization & Depletion | $166.00M | $163.40M | $162.10M | $665.90M | $177.70M |
| -Depreciation & Amortization | $166.00M | $163.40M | $162.10M | $665.90M | $177.70M |
| Operating Profit | $341.50M | $374.00M | $395.10M | $1.36B | $282.60M |
| Net Non-Operating Interest Income (Expense) | -$74.90M | -$72.90M | -$68.80M | -$292.80M | -$71.90M |
| Non-Operating Interest Expense | $74.90M | $72.90M | $68.80M | $292.80M | $71.90M |
| Other Income (Expense) | -$36.50M | -$46.00M | -$24.90M | -$232.60M | -$112.80M |
| Special Income (Charges) | -$34.00M | -$47.90M | -$21.90M | -$258.10M | -$128.20M |
| -Less:Restructuring and Mergern & Acquisition | $34.00M | $47.90M | $21.90M | $258.10M | $128.20M |
| Other Non-Operating Income (Expenses) | -$2.50M | $1.90M | -$3.00M | $25.50M | $15.40M |
| Pretax Profit | $230.10M | $255.10M | $301.30M | $830.80M | $98.00M |
| Tax | $37.20M | $55.50M | $63.00M | $125.70M | -$39.90M |
| Net Profit | $192.90M | $199.60M | $238.30M | $705.10M | $137.90M |
| Profit from Continuing Operations | $192.90M | $199.60M | $238.30M | $705.10M | $137.90M |
| Minority Interests | $1.30M | $1.30M | $200,000.00 | -$100,000.00 | -$1.50M |
| Net Income to Parent Company | $191.60M | $198.30M | $238.10M | $705.10M | $139.30M |
| Net Income to Common Stockholders | $191.60M | $198.30M | $238.10M | $705.10M | $139.30M |
| Basic EPS | $1.01 | $1.03 | $1.22 | $3.56 | $0.71 |
| Diluted EPS | $1.00 | $1.03 | $1.22 | $3.55 | $0.71 |
| Dividend Per Share | $0.24 | $0.24 | $0.24 | $0.96 | $0.24 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $23.54B | $22.80B | $22.72B | $23.09B | $23.09B |
| Total Current Assets | $5.13B | $5.10B | $4.96B | $5.12B | $5.12B |
| Cash and Cash Equivalents & Short-Term Investments | $399.90M | $410.00M | $424.20M | $591.90M | $591.90M |
| -Cash and Cash Equivalents | $399.90M | $410.00M | $424.20M | $591.90M | $591.90M |
| Receivables | $1.82B | $1.77B | $1.73B | $1.70B | $1.70B |
| -Accounts Receivable | $1.82B | $1.77B | $1.73B | $1.70B | $1.70B |
| Inventory | $2.37B | $2.27B | $2.25B | $2.29B | $2.29B |
| Other Current Assets | $545.90M | $646.90M | $562.90M | $537.20M | $537.20M |
| Total Non-Current Assets | $18.41B | $17.70B | $17.76B | $17.97B | $17.97B |
| Net PPE | $2.31B | $2.24B | $2.21B | $2.21B | $2.21B |
| -Gross PPE | $7.60B | $7.42B | $7.30B | $7.26B | $7.26B |
| -Accumulated Depreciation | -$5.29B | -$5.18B | -$5.09B | -$5.05B | -$5.05B |
| Goodwill and Other Intangible Assets | $14.97B | $14.38B | $14.48B | $14.66B | $14.66B |
| -Goodwill | $10.34B | $9.92B | $9.93B | $9.95B | $9.95B |
| -Other Intangible Assets | $4.64B | $4.46B | $4.55B | $4.72B | $4.72B |
| Other Non-Current Assets | $1.13B | $1.08B | $1.07B | $1.10B | $1.10B |
| Total Liabilities | $10.81B | $10.17B | $10.04B | $10.39B | $10.39B |
| Total Current Liabilities | $3.50B | $3.01B | $2.86B | $2.58B | $2.58B |
| Payables | $357.50M | $352.40M | $361.20M | $303.00M | $303.00M |
| -Accounts Payable | $357.50M | $352.40M | $361.20M | $303.00M | $303.00M |
| Short-Term Debt and Capital Lease Obligation | $1.29B | $1.20B | $1.18B | $587.10M | $587.10M |
| -Current Debt | $1.29B | $1.20B | $1.18B | $587.10M | $587.10M |
| Other Current Liabilities | $1.86B | $1.13B | $1.03B | $382.00M | $382.00M |
| Total Non-Current Liabilities | $7.31B | $7.15B | $7.18B | $7.80B | $7.80B |
| Long Term Debt and Capital Lease Obligation | $6.22B | $6.28B | $6.30B | $6.93B | $6.93B |
| -Long Term Debt | $6.22B | $6.28B | $6.30B | $6.93B | $6.93B |
| Non-Current Deferred Liabilities | $265.00M | $235.60M | $249.90M | $244.10M | $244.10M |
| Other Non-Current Liabilities | $829.10M | $638.70M | $630.70M | $626.10M | $626.10M |
| Total Equity | $12.73B | $12.63B | $12.68B | $12.71B | $12.71B |
| Stockholders' Equity | $12.72B | $12.62B | $12.67B | $12.70B | $12.70B |
| Capital Stock | $3.20M | $3.20M | $3.20M | $3.20M | $3.20M |
| -Common Stock | $3.20M | $3.20M | $3.20M | $3.20M | $3.20M |
| Additional Paid-In Capital | $10.26B | $10.22B | $10.20B | $10.18B | $10.18B |
| Retained Earnings | $12.10B | $11.96B | $11.80B | $11.61B | $11.61B |
| Less: Treasury Stock | -$9.47B | -$9.39B | -$9.14B | -$8.89B | -$8.89B |
| Gains/Losses Not Affecting Retained Earnings | -$174.10M | -$163.90M | -$190.40M | -$205.70M | -$205.70M |
| Other Equity Interests | $100,000.00 | – | – | – | – |
| Minority Interests | $10.00M | $8.70M | $8.20M | $8.10M | $8.10M |
| Current Accrued Expenses | – | $334.30M | $293.90M | $1.31B | $1.31B |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $560.00M | $447.80M | $359.40M | $1.70B | $517.40M |
| Net cash flow from continuing operations | $560.00M | $447.80M | $359.40M | $1.70B | $517.40M |
| Net Income from Continuing Operations | $193.00M | $199.60M | $238.30M | $705.10M | $137.90M |
| Depreciation & Depletion & Amortization | $282.00M | $270.80M | $270.00M | $1.09B | $284.00M |
| Change in Working Capital | $60.90M | -$47.10M | -$173.30M | -$104.90M | $158.60M |
| -Change in Receivables | -$24.90M | -$38.50M | $14.50M | -$127.30M | -$111.70M |
| -Change in Inventory | -$79.90M | -$30.50M | -$20.90M | $98.20M | $184.40M |
| -Change in Payables and Accrued Expense | $121.60M | $92.00M | -$183.00M | $101.80M | $112.90M |
| -Change In Other Working Capital | $44.10M | -$70.10M | $16.10M | -$177.60M | -$27.00M |
| Net cash flow from investing | -$543.30M | -$190.80M | -$159.00M | -$1.98B | -$322.00M |
| Net Cash Flow from Continuing Investing Activities | -$543.30M | -$190.80M | -$159.00M | -$1.98B | -$322.00M |
| Net PPE Purchase and Sale | -$75.80M | -$54.20M | -$36.30M | -$224.50M | -$74.80M |
| Net Intangibles Purchase and Sale | -$25.00M | -$62.20M | -$39.00M | -$52.40M | -$10.00M |
| Net Business Purchase and Sale | -$359.40M | – | – | -$1.39B | -$166.90M |
| Net Investment Purchase and Sale | -$83.10M | -$74.30M | -$77.50M | -$300.90M | -$69.40M |
| Net Other Investing Changes | $0.00 | -$100,000.00 | -$6.20M | -$4.70M | -$900,000.00 |
| Financing Cash Flow | -$27.20M | -$271.10M | -$369.20M | $326.00M | -$897.00M |
| Net Cash Flow from Continuing Financing Activities | -$27.20M | -$271.10M | -$369.20M | $326.00M | -$897.00M |
| Net Issuance Payments Of Debt | $90.00M | $30.00M | $0.00 | $1.03B | -$600.00M |
| Net Common Stock Issuance | -$78.50M | -$250.70M | -$250.10M | -$487.00M | -$250.00M |
| Cash Dividends Paid | -$45.80M | -$46.50M | -$46.90M | -$190.30M | -$47.50M |
| Proceeds from Stock Option Exercised | $13.40M | $100,000.00 | $12.30M | $39.70M | $1.70M |
| Net Other Financing Charges | -$6.30M | -$4.00M | -$84.50M | -$65.50M | -$1.20M |
| Ending Cash Balance | $399.90M | $410.00M | $424.20M | $591.90M | $591.90M |
| Net Change in Cash | -$10.50M | -$14.20M | -$168.80M | $47.40M | -$701.60M |
| Beginning Cash Balance | $410.00M | $424.20M | $591.90M | $525.50M | $1.29B |
| Effect of Exchange Rate Changes | $400,000.00 | $0.00 | $1.10M | $19.00M | $800,000.00 |
| Free Cash Flow | $459.20M | $331.40M | $284.10M | $1.42B | $432.60M |
| Other Non-Cash Items | – | -$100,000.00 | $200,000.00 | $100,000.00 | $0.00 |
| Deferred Tax | – | – | – | -$87.20M | – |
No comments yet — be the first to weigh in on ZBH.
Sign in to join the discussion.